RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+10.59%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$998M
AUM Growth
+$998M
(+2.1%)
Cap. Flow
-$70.6M
Cap. Flow
% of AUM
-7.08%
Top 10 Holdings %
Top 10 Hldgs %
28.11%
Holding
91
New
2
Increased
24
Reduced
43
Closed
3
Top Buys
| 1 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
$20M |
| 2 |
Cigna
CI
|
$9.22M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$7.15M |
| 4 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$6.77M |
| 5 |
Biogen
BIIB
|
$6.01M |
Top Sells
Sector Composition
| 1 | Healthcare | 91.36% |
| 2 | Financials | 1.12% |
| 3 | Technology | 0.14% |
| 4 | Energy | 0.14% |
| 5 | Communication Services | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOXO
51
DELISTED
Loxo Oncology, Inc
LOXO
| $8.54M | 0.86% |
50,000
-72,961
| -59% | -$12.5M |
|
52
Xencor
XNCR
$594M
| $8.18M | 0.82% |
209,854
-6,589
| -3% | -$257K |
|
|
ONCE
53
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $7.51M | 0.75% |
137,691
-39,909
| -22% | -$2.18M |
|
54
MacroGenics
MGNX
$121M
| $7.32M | 0.73% |
341,586
+16,586
| +5% | +$356K |
|
55
Omnicell
OMCL
$1.51B
| $7.22M | 0.72% |
100,375
-10,000
| -9% | -$719K |
|
56
Regeneron Pharmaceuticals
REGN
$59.8B
| $6.87M | 0.69% |
17,000
| – | – |
|
57
Rigel Pharmaceuticals
RIGL
$710M
| $6.79M | 0.68% |
211,399
+41,071
| +24% | +$1.32M |
|
|
PTLA
58
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $6.45M | 0.65% |
242,302
-110,000
| -31% | -$2.93M |
|
59
Pediatrix Medical
MD
$1.45B
| $5.82M | 0.58% |
+124,674
| New | +$5.82M |
|
60
Centene
CNC
$14.8B
| $5.79M | 0.58% |
80,000
-50,000
| -38% | -$3.62M |
|
|
ADMS
61
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $5.48M | 0.55% |
273,593
-54,600
| -17% | -$1.09M |
|
62
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $5.46M | 0.55% |
331,131
-18,869
| -5% | -$311K |
|
|
RVNC
63
DELISTED
Revance Therapeutics, Inc.
RVNC
| $5.05M | 0.51% |
203,181
| – | – |
|
|
VRAY
64
DELISTED
ViewRay, Inc.
VRAY
| $4.84M | 0.48% |
516,623
| – | – |
|
|
MDCO
65
DELISTED
Medicines Co
MDCO
| $4.04M | 0.4% |
135,000
+25,000
| +23% | +$748K |
|
|
ZGNX
66
DELISTED
Zogenix, Inc.
ZGNX
| $2.98M | 0.3% |
60,000
+10,000
| +20% | +$496K |
|
|
ACHN
67
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $2.27M | 0.23% |
617,800
| – | – |
|
|
PVLA
68
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
| $1.68M | 0.17% |
3,750
| – | – |
|
|
CMRX
69
DELISTED
Chimerix, Inc.
CMRX
| $1.33M | 0.13% |
341,300
-700
| -0.2% | -$2.72K |
|
|
PDCO
70
DELISTED
Patterson Companies, Inc.
PDCO
| $941K | 0.09% |
+38,500
| New | +$941K |
|
71
Adverum Biotechnologies
ADVM
$68.2M
| $931K | 0.09% |
15,397
| – | – |
|
|
VIRX
72
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $855K | 0.09% |
12,218
| – | – |
|
73
Exxon Mobil
XOM
$477B
| $520K | 0.05% |
6,111
-693
| -10% | -$59K |
|
74
Qualcomm
QCOM
$170B
| $466K | 0.05% |
6,476
-771
| -11% | -$55.5K |
|
75
Chevron
CVX
$318B
| $456K | 0.05% |
3,733
| – | – |
|